Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Myung Jin Oh, Heon Ju Lee, Si Hyung Lee

Clin Mol Hepatol. 2013;19(3):288-299. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.288

View: 8227 Download: 75 Crossref: 10

Heon Ju Lee, Myung Jin Oh

Clin Mol Hepatol. 2013;19(2):179-184. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.179

View: 7007 Download: 77 Crossref: 9

Myung Jin Oh, Heon Ju Lee

Clin Mol Hepatol. 2013;19(1):51-59. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.51

View: 7447 Download: 78 Web of Science: 23 Crossref: 23

1 |

Viewed By 5145	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5007	MAFLD: How is it different from NAFLD?
Viewed By 4914	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3641	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3582	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 67	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search